PV-0474: Pelvic re-irradiation with Stereotactic Ablative Radiotherapy (SABR): outcomes and cumulative doses

Murray, L, Speight, R, Dickinson, P et al. (4 more authors) (2018) PV-0474: Pelvic re-irradiation with Stereotactic Ablative Radiotherapy (SABR): outcomes and cumulative doses. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S243-S244.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Elsevier Ireland Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/.
Dates:
  • Accepted: 18 December 2017
  • Published (online): 18 June 2018
  • Published: April 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP)
Funding Information:
FunderGrant number
Yorkshire Cancer ResearchNot Known
Depositing User: Symplectic Publications
Date Deposited: 07 Aug 2018 14:50
Last Modified: 08 Aug 2018 08:06
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S0167-8140(18)30784-9

Export

Statistics


CORE (COnnecting REpositories)